APCs	Antigen presenting cells
BC	Breast cancer
BL1	Basal-like 1
BL2	Basal-like 2
CTLA-4	Cytotoxic T-lymphocyte-associated antigen-4
DEGs	Differentially expressed genes
FBP1	Fructose-1,6-bisphosphatase
FDA	Food and Drug Administration
FDR	False discovery rate
GDPS	Genomics of Drug Sensitivity in Cancer
GO	Gene Ontology
GSVA	Gene Set Variation Analysis
GSEA	Gene set enrichment Analysis
ICIs	Immune checkpoint inhibitors
IM	Immunomodulatory
IPS	Immunophenoscore
IRGs	Immune-related genes
IRGP	Immune-related gene panel
KEGG	Kyoto Encyclopedia of Genes and Genomes
LAR	Luminal androgen receptor
LASSO	Least absolute shrinkage and selection operator
M	Mesenchymal
METABRIC	Molecular Taxonomy of Breast Cancer International Consortium
MHC	Major histocompatibility complex
MSL	Mesenchymal stem-like
OS	Overall survival
PARP	Poly (ADP-ribose) polymerase
PCA	Principal component analysis
PD-1	Programmed cell death receptor 1
PD-L1	Programmed cell death 1 ligand 1
ROC	Receiver operating characteristic
ssGSEA	Single-sample gene-set enrichment analysis
STAT3	Signal transducer and activator of transcription 3
TAPBPL	TAP binding protein like
TCGA	The Cancer Genome Atlas
TILs	Tumor infiltrating lymphocytes
TNBC	Triple-negative breast cancer
TOM	Topological overlap matrix
t-SNE	t-distributed stochastic neighbor embedding
WGCNA	Weighted gene co-expression network analysis